Status: Recruiting
A Long-Term Follow-Up Study of Participants Exposed to REACT
The purpose of this study is to evaluate the long-term safety of up to two gelatin-hydrogel formulation REACT injections given 3 to 6 months apart and delivered percutaneously into same kidney on renal function in participants with chronic kidney disease (CKD).
Participants needed: 80
Trial details
Age: 30-80Biological sex: AllType: ObservationalSponsor: ProkidneyUpdated: May 28, 2025Locations: 1
Eligibility criteria
The participant must have received gelatin-hydrogel formulation REACT in a previ...
The participant did not receive REACT in a previous trial for the treatment of c...